122 related articles for article (PubMed ID: 38846300)
1. Changes in bone turnover markers and bone mineral density after radiofrequency ablation for mild primary hyperparathyroidism: a prospective cohort study.
Han Z; Xue Y; Liang L; Xie J; Zhou Z
Quant Imaging Med Surg; 2024 Jun; 14(6):3828-3836. PubMed ID: 38846300
[TBL] [Abstract][Full Text] [Related]
2. The threshold of bone mineral density for vertebral fractures in female patients with primary hyperparathyroidism.
Kaji H; Yamauchi M; Chihara K; Sugimoto T
Eur J Endocrinol; 2005 Sep; 153(3):373-8. PubMed ID: 16131599
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.
Guo CY; Thomas WE; al-Dehaimi AW; Assiri AM; Eastell R
J Clin Endocrinol Metab; 1996 Oct; 81(10):3487-91. PubMed ID: 8855790
[TBL] [Abstract][Full Text] [Related]
4. Positive Effect of Parathyroidectomy Compared to Observation on BMD in a Randomized Controlled Trial of Mild Primary Hyperparathyroidism.
Lundstam K; Pretorius M; Bollerslev J; Godang K; Fagerland MW; Mollerup C; Fougner SL; Pernow Y; Aas T; Hessman O; Rosén T; Nordenström J; Jansson S; Hellström M; Heck A
J Bone Miner Res; 2023 Mar; 38(3):372-380. PubMed ID: 36593641
[TBL] [Abstract][Full Text] [Related]
5. Positive effect of parathyroidectomy on bone mineral density in mild asymptomatic primary hyperparathyroidism.
Hagström E; Lundgren E; Mallmin H; Rastad J; Hellman P
J Intern Med; 2006 Feb; 259(2):191-8. PubMed ID: 16420548
[TBL] [Abstract][Full Text] [Related]
6. Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism.
Palermo A; Naciu AM; Tabacco G; Falcone S; Santonati A; Maggi D; D'Onofrio L; Briganti SI; Castellitto D; Casini A; Pedone C; Lelli D; Fabbri A; Bilezikian JP; Napoli N; Pozzilli P; Manfrini S; Cesareo R
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32271382
[TBL] [Abstract][Full Text] [Related]
7. Changes in Bone Mineral Density After Parathyroidectomy and Their Relations With Biochemical Markers of Bone Metabolism.
Xu Q; Kong N; Zhang Z; Cui A; Tan S; Bai N
Am Surg; 2023 Jun; 89(6):2450-2454. PubMed ID: 35570721
[TBL] [Abstract][Full Text] [Related]
8. Does Baseline PTH Influence Recovery of Bone Mineral Density, Trabecular Bone Score and Bone Turnover Markers? A Prospective Study Following Curative PArathyroidectomy in Primary Hyperparathyroidism.
Shetty S; Cherian KE; Shetty S; Kapoor N; Jebasingh FK; Cherian A; Hephzibah J; Chandramohan A; John RA; Asha HS; Paul MJ; Manipadam MT; Abraham DT; Thomas N; Paul TV
Endocr Pract; 2020 Dec; 26(12):1442-1450. PubMed ID: 33471736
[TBL] [Abstract][Full Text] [Related]
9. Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization.
Colao A; Di Somma C; Loche S; Di Sarno A; Klain M; Pivonello R; Pietrosante M; Salvatore M; Lombardi G
Clin Endocrinol (Oxf); 2000 Mar; 52(3):319-27. PubMed ID: 10718830
[TBL] [Abstract][Full Text] [Related]
10. Phalangeal quantitative ultrasound technology and dual energy X-ray densitometry in patients with primary hyperparathyroidism: influence of sex and menopausal status.
Camozzi V; Lumachi F; Mantero F; Piccolo M; Luisetto G
Osteoporos Int; 2003 Jul; 14(7):602-8. PubMed ID: 12730752
[TBL] [Abstract][Full Text] [Related]
11. Lumbar spine bone mineral density changes in patients with primary hyperparathyroidism according to age and gender.
Lumachi F; Camozzi V; Ermani M; Nardi A; Luisetto G
Ann N Y Acad Sci; 2007 Nov; 1117():362-6. PubMed ID: 17656570
[TBL] [Abstract][Full Text] [Related]
12. Effect of Surgery Versus Observation: Skeletal 5-Year Outcomes in a Randomized Trial of Patients With Primary HPT (the SIPH Study).
Lundstam K; Heck A; Godang K; Mollerup C; Baranowski M; Pernow Y; Aas T; Hessman O; Rosén T; Nordenström J; Jansson S; Hellström M; Bollerslev J;
J Bone Miner Res; 2017 Sep; 32(9):1907-1914. PubMed ID: 28543873
[TBL] [Abstract][Full Text] [Related]
13. Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial.
Khan AA; Bilezikian JP; Kung AW; Ahmed MM; Dubois SJ; Ho AY; Schussheim D; Rubin MR; Shaikh AM; Silverberg SJ; Standish TI; Syed Z; Syed ZA
J Clin Endocrinol Metab; 2004 Jul; 89(7):3319-25. PubMed ID: 15240609
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of radiofrequency ablation for primary and secondary hyperparathyroidism: a retrospective study.
Qiu X; Gao M; Zhang D; Ji F
Sci Rep; 2023 Oct; 13(1):16949. PubMed ID: 37805586
[TBL] [Abstract][Full Text] [Related]
15. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation for primary hyperparathyroidism and risk factors for postablative eucalcemic parathyroid hormone elevation.
Peng CZ; Chai HH; Zhang ZX; Hu QH; Zeng Z; Cui AL; Pang HS; Ruan LT
Int J Hyperthermia; 2022; 39(1):490-496. PubMed ID: 35285391
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of primary hyperparathyroidism and impact on bone mineral density in elderly men: MrOs Sweden.
Siilin H; Lundgren E; Mallmin H; Mellström D; Ohlsson C; Karlsson M; Orwoll E; Ljunggren O
World J Surg; 2011 Jun; 35(6):1266-72. PubMed ID: 21445668
[TBL] [Abstract][Full Text] [Related]
18. Changes in bone mass and serum markers of bone metabolism after parathyroidectomy.
Thorsen K; Kristoffersson AO; Lorentzon RP
Surgery; 1997 Nov; 122(5):882-7. PubMed ID: 9369887
[TBL] [Abstract][Full Text] [Related]
19. Increased biochemical markers of bone formation and resorption in primary hyperparathyroidism with special reference to patients with mild disease.
Valdemarsson S; Lindergård B; Tibblin S; Bergenfelz A
J Intern Med; 1998 Feb; 243(2):115-22. PubMed ID: 9566639
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of changes in bone density and biochemical parameters after parathyroidectomy in primary hyperparathyroidism.
Nakaoka D; Sugimoto T; Kobayashi T; Yamaguchi T; Kobayashi A; Chihara K
Endocr J; 2000 Jun; 47(3):231-7. PubMed ID: 11036865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
